Betsy J. Bernard - 10 May 2024 Form 4 Insider Report for ZIMMER BIOMET HOLDINGS, INC. (ZBH)

Role: Director
Signature: /s/ Matthew R. St. Louis, Attorney-in-Fact for Betsy J. Bernard (power of attorney previously filed)
Issuer symbol: ZBH
Transactions as of: 10 May 2024
Net transactions value: $0
Form type: 4
Filing time: 14 May 2024, 17:00:39 UTC
Previous filing: 03 Jan 2024
Next filing: 02 Jun 2025
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ZBH	Phantom Stock Units	Award	$0	+617	+3.3%	$0.000000	19,501	10 May 2024	Common Stock	617	$121.61	Direct	F1, F2, F3, F4
transaction	ZBH	Restricted Stock Units	Award	$0	+1,069	+5.2%	$0.000000	21,578	10 May 2024	Common Stock	1,069		Direct	F2, F5, F6

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. (the "Company") Deferred Compensation Plan for Non-Employee Directors.
F2	The Conversion or Exercise Price of Derivative Security is 1-for-1.
F3	These units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.
F4	Includes 35.416 phantom stock units accrued on January 31, 2024 and 37.432 phantom stock units accrued on April 30, 2024 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
F5	The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.
F6	Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods.